XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Shareholders’ Equity and Redeemable Noncontrolling Interest (unaudited) - USD ($)
Total
Common Stock
Deferred Equity Compensation
Retained Earnings
Beginning balance (shares) at Dec. 31, 2017   3,470,428    
Beginning Balance at Dec. 31, 2017 $ 172,443,820 $ 118,209,111 $ (19,134,963) $ 73,369,672
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (shares)   32,050    
Issuance of restricted stock grants   $ 6,755,108 (6,755,108)  
Amortization of restricted stock grants 1,378,923   1,378,923  
Issuance of stock grants (shares)   20,153    
Issuance of stock grants 4,109,197 $ 4,109,197    
Issuance of common stock related to 401k plan match (shares)   2,253    
Issuance of common stock related to 401k plan match 472,779 $ 472,779    
Shares withheld related to employee tax withholding (shares)   (2,427)    
Shares withheld related to employee tax withholding (501,564) $ (501,564)    
Forfeiture of restricted stock grants (shares)   (3,500)    
Forfeiture of restricted stock grants   $ (603,400) 603,400  
Net income 12,989,461     12,989,461
Ending balance (shares) at Mar. 31, 2018   3,518,957    
Ending Balance at Mar. 31, 2018 190,892,616 $ 128,441,231 (23,907,748) 86,359,133
Beginning balance attributable to redeemable noncontrolling Interests at Dec. 31, 2017 20,076,806      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net Income Attributable to Redeemable Noncontrolling Interest (47,332)      
Net subscriptions of consolidated funds 5,186,193      
Net consolidations (deconsolidations) of Company sponsored investments 16,444,640      
Ending balance attributable to redeemable noncontrolling Interests at Mar. 31, 2018 $ 41,660,307      
Beginning balance (shares) at Dec. 31, 2018 3,470,428 3,499,285    
Beginning Balance at Dec. 31, 2018 $ 195,575,943 $ 124,933,060 (22,008,054) 92,650,937
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (shares)   24,875    
Issuance of restricted stock grants   $ 3,859,300 (3,859,300)  
Amortization of restricted stock grants 1,521,974   1,521,974  
Issuance of stock grants (shares)   24,048    
Issuance of stock grants 3,655,296 $ 3,655,296    
Issuance of common stock related to 401k plan match (shares)   4,286    
Issuance of common stock related to 401k plan match 632,050 $ 632,050    
Forfeiture of restricted stock grants (shares)   (4,250)    
Forfeiture of restricted stock grants   $ (688,606) 688,606  
Repurchase of common stock (shares)   (53,645)    
Repurchase of common stock (7,907,055) $ (7,907,055)    
Net income $ 16,932,642     16,932,642
Ending balance (shares) at Mar. 31, 2019 3,494,599 3,494,599    
Ending Balance at Mar. 31, 2019 $ 210,410,850 $ 124,484,045 $ (23,656,774) $ 109,583,579
Beginning balance attributable to redeemable noncontrolling Interests at Dec. 31, 2018 62,679,687      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net Income Attributable to Redeemable Noncontrolling Interest 2,623,205      
Net subscriptions of consolidated funds (1,728,877)      
Net consolidations (deconsolidations) of Company sponsored investments (27,324,561)      
Ending balance attributable to redeemable noncontrolling Interests at Mar. 31, 2019 $ 36,249,454